A new study has found that cholesterol-lowering medicines, statins, are effective in the treatment of cancer.
The research from the University of Gothenburg has been published in the prestigious journal PNAS.Statins lower cholesterol by blocking certain enzymes involved in our metabolism. However, they have also been shown to affect other important lipids in the body, such as the lipids that help proteins to attach to the cell membrane (known as lipid modification). Because many of the proteins that are lipid-modified cause cancer, there are now hopes that it will be possible to use statins in the treatment of cancer.
Ideal test subject
It is, however, very difficult to study the side-effects of statins in mammals. As a first step, Marc Pilon, researcher at the Department of Cell and Molecular Biology at the University of Gothenburg, has teamed up with Swedish and international colleagues to carry out studies on the nematode C. elegans. This nematode, which is made up of just a thousand or so cells, does not produce cholesterol and is therefore an ideal test subject.
The Gothenburg researchers' studies show that statins can have a dramatic inhibitory effect on growth and development. As the researchers managed to identify the enzyme involved, they can also explain how the effect arises at molecular level.
"Our results support the idea that statins can be used in more ways than just to lower cholesterol," says Pilon.
Advertisement
Statins 'Cut Heart Attack Risk by 30pct'
Cholesterol lowering drugs Statins could decrease the risk of heart attacks in healthy people by 30 per cent, according to a new study.
Cholesterol lowering drugs Statins could decrease the risk of heart attacks in healthy people by 30 per cent, according to a new study.
Source-ANI
TAN
